SlideShare une entreprise Scribd logo
1  sur  37
Beyond the Business Plan ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Presentation starts on next page For more information: Yali Friedman, Ph.D. [email_address] www.BuildingBiotechnology.com
Beyond the Business Plan Managing unexpected risks in biotechnology business development Yali Friedman, Ph.D. – info@thinkbiotech.com
Beyond the Business Plan ,[object Object],[object Object],[object Object]
Business risks ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Freedom to operate ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  Chp 7, p. 267
Amgen v. Transkaryotic:  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p. 120
Monsanto hit by submarine patent ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p. 126
Manufacturing problems ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  pp. 202, 346-7, 161
Lessons ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
If you build it, they might not come ,[object Object],[object Object],[object Object],[object Object],[object Object]
Evacyte: Classic technology push ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  pp. 264-265
Calgene’s Flavr Savr tomato ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p. 326
Path to development ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Market launch ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Why do companies aim for empty markets? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Estimating market size ,[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  pp  235-239, 273-276
Resolving valuation disagreements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 304
Low estimates can be detrimental ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 275
Lessons ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Off-label use ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  pp 148-150
Fen-Phen: Yes, you can be too popular ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 150
Fentora: Don’t buy our drug ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 148
Avastin: Controlling off-label use ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 282
Lessons ,[object Object],[object Object]
Shareholder / board activism BUILDING BIOTECHNOLOGY  pp. 193-197
Dyadic:  Et tu Brute ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Shareholder letter
Founder regains control … of what?
MedImmune: Shareholder activism ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  pp. 195
With partners like these, who needs competitors ,[object Object],[object Object],[object Object],[object Object],[object Object]
Suing the Red Cross ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 131
IP disputes with major backers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  p 186
Nektar: Running with the big dogs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BUILDING BIOTECHNOLOGY  pp.250-251, 308
Lessons ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The business plan is but the beginning ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Yali Friedman – info@thinkbiotech.com
Building Biotechnology on Facebook ,[object Object],[object Object],[object Object],[object Object],[object Object]

Contenu connexe

Tendances

Investor presentation april_2012-1
Investor presentation april_2012-1Investor presentation april_2012-1
Investor presentation april_2012-1rymankoly
 
Investor presentation april_2012
Investor presentation april_2012Investor presentation april_2012
Investor presentation april_2012rymankoly
 
BIOSIMILARS - Regulation and Market Trends
BIOSIMILARS - Regulation and Market Trends    BIOSIMILARS - Regulation and Market Trends
BIOSIMILARS - Regulation and Market Trends Joseph Pategou
 
Innovation and entrepreneurship in biotechnology an intl perspective - d. h...
Innovation and entrepreneurship in biotechnology   an intl perspective - d. h...Innovation and entrepreneurship in biotechnology   an intl perspective - d. h...
Innovation and entrepreneurship in biotechnology an intl perspective - d. h...sanguru1977
 
Imugene corporate deck jan18
Imugene corporate deck jan18Imugene corporate deck jan18
Imugene corporate deck jan18tttinor
 
Leading Molecules to Market - An overview on licensing
 Leading Molecules to Market - An overview on licensing Leading Molecules to Market - An overview on licensing
Leading Molecules to Market - An overview on licensingBananaIP Counsels
 
PharmAust: A Leader In Pharmaceutical Research & Discovery
PharmAust: A Leader In Pharmaceutical Research & DiscoveryPharmAust: A Leader In Pharmaceutical Research & Discovery
PharmAust: A Leader In Pharmaceutical Research & DiscoveryRedChip Companies, Inc.
 
Merck: Global Health and Access to Medicines
Merck: Global Health and Access to  MedicinesMerck: Global Health and Access to  Medicines
Merck: Global Health and Access to MedicinesTony Sebastian
 
Investor presentation _-_march_2012_2
Investor presentation _-_march_2012_2Investor presentation _-_march_2012_2
Investor presentation _-_march_2012_2rymankoly
 
RiskAssessmentCBIFalcon25June2012
RiskAssessmentCBIFalcon25June2012RiskAssessmentCBIFalcon25June2012
RiskAssessmentCBIFalcon25June2012Robert Falcon
 
AIS Investor presentation january 2011
AIS Investor presentation january 2011AIS Investor presentation january 2011
AIS Investor presentation january 2011rymankoly
 
Importance Of Patents In The Life Sciences Industry
Importance Of Patents In The Life Sciences IndustryImportance Of Patents In The Life Sciences Industry
Importance Of Patents In The Life Sciences Industrybatane
 

Tendances (15)

Investor presentation april_2012-1
Investor presentation april_2012-1Investor presentation april_2012-1
Investor presentation april_2012-1
 
Investor presentation april_2012
Investor presentation april_2012Investor presentation april_2012
Investor presentation april_2012
 
AMI August Investor Presentation
AMI  August Investor PresentationAMI  August Investor Presentation
AMI August Investor Presentation
 
BIOSIMILARS - Regulation and Market Trends
BIOSIMILARS - Regulation and Market Trends    BIOSIMILARS - Regulation and Market Trends
BIOSIMILARS - Regulation and Market Trends
 
Innovation and entrepreneurship in biotechnology an intl perspective - d. h...
Innovation and entrepreneurship in biotechnology   an intl perspective - d. h...Innovation and entrepreneurship in biotechnology   an intl perspective - d. h...
Innovation and entrepreneurship in biotechnology an intl perspective - d. h...
 
Imugene corporate deck jan18
Imugene corporate deck jan18Imugene corporate deck jan18
Imugene corporate deck jan18
 
Leading Molecules to Market - An overview on licensing
 Leading Molecules to Market - An overview on licensing Leading Molecules to Market - An overview on licensing
Leading Molecules to Market - An overview on licensing
 
Imugene (ASX: IMU)
Imugene (ASX: IMU)Imugene (ASX: IMU)
Imugene (ASX: IMU)
 
PharmAust: A Leader In Pharmaceutical Research & Discovery
PharmAust: A Leader In Pharmaceutical Research & DiscoveryPharmAust: A Leader In Pharmaceutical Research & Discovery
PharmAust: A Leader In Pharmaceutical Research & Discovery
 
PTX
PTXPTX
PTX
 
Merck: Global Health and Access to Medicines
Merck: Global Health and Access to  MedicinesMerck: Global Health and Access to  Medicines
Merck: Global Health and Access to Medicines
 
Investor presentation _-_march_2012_2
Investor presentation _-_march_2012_2Investor presentation _-_march_2012_2
Investor presentation _-_march_2012_2
 
RiskAssessmentCBIFalcon25June2012
RiskAssessmentCBIFalcon25June2012RiskAssessmentCBIFalcon25June2012
RiskAssessmentCBIFalcon25June2012
 
AIS Investor presentation january 2011
AIS Investor presentation january 2011AIS Investor presentation january 2011
AIS Investor presentation january 2011
 
Importance Of Patents In The Life Sciences Industry
Importance Of Patents In The Life Sciences IndustryImportance Of Patents In The Life Sciences Industry
Importance Of Patents In The Life Sciences Industry
 

En vedette

Business plan
Business planBusiness plan
Business planStudent
 
Economic Development Lands Planning Pilot Project
Economic Development Lands Planning Pilot ProjectEconomic Development Lands Planning Pilot Project
Economic Development Lands Planning Pilot Projecticablearning
 
Leading Virtual Teams In The Pharma And Biotech World.Ppt
Leading Virtual Teams In The Pharma And Biotech World.PptLeading Virtual Teams In The Pharma And Biotech World.Ppt
Leading Virtual Teams In The Pharma And Biotech World.Pptlyndamcdermott
 
Rivergreen Residences Presentation
Rivergreen Residences PresentationRivergreen Residences Presentation
Rivergreen Residences PresentationJohn Michael Pacheo
 
Perak biotechnology business plan
Perak biotechnology business planPerak biotechnology business plan
Perak biotechnology business planjongos89
 
Partner Training: Business Plan Development
Partner Training: Business Plan DevelopmentPartner Training: Business Plan Development
Partner Training: Business Plan DevelopmentBizcentralUSA
 
BioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of BiotechBioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of BiotechMaRS Discovery District
 
Project Plan Development - A FlackVentures Training Example
Project Plan Development - A FlackVentures Training ExampleProject Plan Development - A FlackVentures Training Example
Project Plan Development - A FlackVentures Training ExampleKate Pynn
 
Business Plan on a Bio-Tech product
Business Plan on a Bio-Tech productBusiness Plan on a Bio-Tech product
Business Plan on a Bio-Tech productTarkeshwar Singh
 
Genetically modified foods
Genetically modified foodsGenetically modified foods
Genetically modified foods14nieman
 
Individual Development Plan For Peter Stinson Draft March 2008
Individual Development Plan For  Peter Stinson   Draft   March 2008Individual Development Plan For  Peter Stinson   Draft   March 2008
Individual Development Plan For Peter Stinson Draft March 2008Peter Stinson
 
Building Your Customer Development Plan
Building Your Customer Development PlanBuilding Your Customer Development Plan
Building Your Customer Development PlanCindy Alvarez
 
Example Business Plan Presentation - Steamboat Leleh
Example Business Plan Presentation - Steamboat Leleh Example Business Plan Presentation - Steamboat Leleh
Example Business Plan Presentation - Steamboat Leleh normaisarah71
 

En vedette (17)

Business plan
Business planBusiness plan
Business plan
 
Economic Development Lands Planning Pilot Project
Economic Development Lands Planning Pilot ProjectEconomic Development Lands Planning Pilot Project
Economic Development Lands Planning Pilot Project
 
Leading Virtual Teams In The Pharma And Biotech World.Ppt
Leading Virtual Teams In The Pharma And Biotech World.PptLeading Virtual Teams In The Pharma And Biotech World.Ppt
Leading Virtual Teams In The Pharma And Biotech World.Ppt
 
AutoDCR
AutoDCRAutoDCR
AutoDCR
 
Rivergreen Residences Presentation
Rivergreen Residences PresentationRivergreen Residences Presentation
Rivergreen Residences Presentation
 
Autodcr level1
Autodcr level1Autodcr level1
Autodcr level1
 
Perak biotechnology business plan
Perak biotechnology business planPerak biotechnology business plan
Perak biotechnology business plan
 
Buisiness Training Plan 2015
Buisiness Training Plan 2015Buisiness Training Plan 2015
Buisiness Training Plan 2015
 
Partner Training: Business Plan Development
Partner Training: Business Plan DevelopmentPartner Training: Business Plan Development
Partner Training: Business Plan Development
 
BioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of BiotechBioEntrepreneurship: The Business of Biotech
BioEntrepreneurship: The Business of Biotech
 
Project Plan Development - A FlackVentures Training Example
Project Plan Development - A FlackVentures Training ExampleProject Plan Development - A FlackVentures Training Example
Project Plan Development - A FlackVentures Training Example
 
Business Plan on a Bio-Tech product
Business Plan on a Bio-Tech productBusiness Plan on a Bio-Tech product
Business Plan on a Bio-Tech product
 
Genetically modified foods
Genetically modified foodsGenetically modified foods
Genetically modified foods
 
Individual Development Plan For Peter Stinson Draft March 2008
Individual Development Plan For  Peter Stinson   Draft   March 2008Individual Development Plan For  Peter Stinson   Draft   March 2008
Individual Development Plan For Peter Stinson Draft March 2008
 
Building Your Customer Development Plan
Building Your Customer Development PlanBuilding Your Customer Development Plan
Building Your Customer Development Plan
 
Example Business Plan Presentation - Steamboat Leleh
Example Business Plan Presentation - Steamboat Leleh Example Business Plan Presentation - Steamboat Leleh
Example Business Plan Presentation - Steamboat Leleh
 
Business Plan
Business PlanBusiness Plan
Business Plan
 

Similaire à Beyond the Business Plan - Managing unexpected risks in biotechnology business development

Functional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology IndustryFunctional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology IndustrythinkBiotech
 
Eli Lilly Global Strategy
Eli Lilly Global StrategyEli Lilly Global Strategy
Eli Lilly Global Strategyguest90d5a
 
Biotechnology 1
Biotechnology 1Biotechnology 1
Biotechnology 1sokraturk
 
Dendreon Presentation
Dendreon PresentationDendreon Presentation
Dendreon Presentationafa4
 
Dendreon Strategic Analysis
Dendreon Strategic AnalysisDendreon Strategic Analysis
Dendreon Strategic Analysisafa4
 
Roche & Alexion M&A Simulation
Roche & Alexion M&A SimulationRoche & Alexion M&A Simulation
Roche & Alexion M&A SimulationAurore Cassin
 
Bio Pharm Collaborations 9 09
Bio Pharm Collaborations 9 09Bio Pharm Collaborations 9 09
Bio Pharm Collaborations 9 09thess1121
 
The Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals IndustryThe Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals IndustryVarsha Chauhan
 
New England Compounding Center and Microbial Contamination ASQ Presentation
New England Compounding Center and Microbial Contamination ASQ PresentationNew England Compounding Center and Microbial Contamination ASQ Presentation
New England Compounding Center and Microbial Contamination ASQ PresentationMicrobiological Environments Inc.
 
Eyf webinar sepa career fair 2010
Eyf webinar sepa career fair 2010Eyf webinar sepa career fair 2010
Eyf webinar sepa career fair 2010elliecantor
 
pharmaceutical-industry-r-d-an-inside-out-look.ppt
pharmaceutical-industry-r-d-an-inside-out-look.pptpharmaceutical-industry-r-d-an-inside-out-look.ppt
pharmaceutical-industry-r-d-an-inside-out-look.pptAsaduddin Abdullah
 
Pharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT TeamsPharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT TeamsSatheesh Kadiam
 
Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21yahyasultan
 
BioEntrepreneurship: Life Science Business Models
BioEntrepreneurship: Life Science Business ModelsBioEntrepreneurship: Life Science Business Models
BioEntrepreneurship: Life Science Business ModelsMaRS Discovery District
 
Focus On Brazil 1.8
Focus On Brazil 1.8Focus On Brazil 1.8
Focus On Brazil 1.8Jay Nadkarni
 
Focus On Brazil 1.7
Focus On Brazil 1.7Focus On Brazil 1.7
Focus On Brazil 1.7Jay Nadkarni
 
Eli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development StrategyEli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development StrategyMohammad Mohtashim
 
Aiden hollis hif presentation berkeley
Aiden hollis   hif presentation berkeleyAiden hollis   hif presentation berkeley
Aiden hollis hif presentation berkeleyOpen Science Summit
 
What's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science CoachWhat's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science CoachDebra A. Chanda
 

Similaire à Beyond the Business Plan - Managing unexpected risks in biotechnology business development (20)

Functional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology IndustryFunctional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology Industry
 
Eli Lilly Global Strategy
Eli Lilly Global StrategyEli Lilly Global Strategy
Eli Lilly Global Strategy
 
Biotechnology 1
Biotechnology 1Biotechnology 1
Biotechnology 1
 
Dendreon Presentation
Dendreon PresentationDendreon Presentation
Dendreon Presentation
 
Dendreon Strategic Analysis
Dendreon Strategic AnalysisDendreon Strategic Analysis
Dendreon Strategic Analysis
 
Roche & Alexion M&A Simulation
Roche & Alexion M&A SimulationRoche & Alexion M&A Simulation
Roche & Alexion M&A Simulation
 
Bio Pharm Collaborations 9 09
Bio Pharm Collaborations 9 09Bio Pharm Collaborations 9 09
Bio Pharm Collaborations 9 09
 
The Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals IndustryThe Role of clinical Research in Pharmaceuticals Industry
The Role of clinical Research in Pharmaceuticals Industry
 
New England Compounding Center and Microbial Contamination ASQ Presentation
New England Compounding Center and Microbial Contamination ASQ PresentationNew England Compounding Center and Microbial Contamination ASQ Presentation
New England Compounding Center and Microbial Contamination ASQ Presentation
 
Eyf webinar sepa career fair 2010
Eyf webinar sepa career fair 2010Eyf webinar sepa career fair 2010
Eyf webinar sepa career fair 2010
 
pharmaceutical-industry-r-d-an-inside-out-look.ppt
pharmaceutical-industry-r-d-an-inside-out-look.pptpharmaceutical-industry-r-d-an-inside-out-look.ppt
pharmaceutical-industry-r-d-an-inside-out-look.ppt
 
Pharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT TeamsPharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT Teams
 
Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21Pharma Focus Asia Issue 21
Pharma Focus Asia Issue 21
 
Genentech
GenentechGenentech
Genentech
 
BioEntrepreneurship: Life Science Business Models
BioEntrepreneurship: Life Science Business ModelsBioEntrepreneurship: Life Science Business Models
BioEntrepreneurship: Life Science Business Models
 
Focus On Brazil 1.8
Focus On Brazil 1.8Focus On Brazil 1.8
Focus On Brazil 1.8
 
Focus On Brazil 1.7
Focus On Brazil 1.7Focus On Brazil 1.7
Focus On Brazil 1.7
 
Eli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development StrategyEli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development Strategy
 
Aiden hollis hif presentation berkeley
Aiden hollis   hif presentation berkeleyAiden hollis   hif presentation berkeley
Aiden hollis hif presentation berkeley
 
What's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science CoachWhat's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science Coach
 

Plus de thinkBiotech

Defeating COVID-19
Defeating COVID-19Defeating COVID-19
Defeating COVID-19thinkBiotech
 
Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...
Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...
Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...thinkBiotech
 
Finding and evaluating branded and generic market entry opportunities
Finding and evaluating branded and generic market entry opportunitiesFinding and evaluating branded and generic market entry opportunities
Finding and evaluating branded and generic market entry opportunitiesthinkBiotech
 
When do drug patents expire and when can generic drugs launch?
When do drug patents expire and when can generic drugs launch?When do drug patents expire and when can generic drugs launch?
When do drug patents expire and when can generic drugs launch?thinkBiotech
 
Educating the Next Generation of Biotechnology Managers and Founders
Educating the Next Generation of Biotechnology Managers and FoundersEducating the Next Generation of Biotechnology Managers and Founders
Educating the Next Generation of Biotechnology Managers and FoundersthinkBiotech
 
Innovating Across Borders
Innovating Across BordersInnovating Across Borders
Innovating Across BordersthinkBiotech
 

Plus de thinkBiotech (6)

Defeating COVID-19
Defeating COVID-19Defeating COVID-19
Defeating COVID-19
 
Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...
Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...
Evaluating innovative portfolios and preparing for branded, 505(b)(2), and ge...
 
Finding and evaluating branded and generic market entry opportunities
Finding and evaluating branded and generic market entry opportunitiesFinding and evaluating branded and generic market entry opportunities
Finding and evaluating branded and generic market entry opportunities
 
When do drug patents expire and when can generic drugs launch?
When do drug patents expire and when can generic drugs launch?When do drug patents expire and when can generic drugs launch?
When do drug patents expire and when can generic drugs launch?
 
Educating the Next Generation of Biotechnology Managers and Founders
Educating the Next Generation of Biotechnology Managers and FoundersEducating the Next Generation of Biotechnology Managers and Founders
Educating the Next Generation of Biotechnology Managers and Founders
 
Innovating Across Borders
Innovating Across BordersInnovating Across Borders
Innovating Across Borders
 

Dernier

14680-51-4.pdf Good quality CAS Good quality CAS
14680-51-4.pdf  Good  quality CAS Good  quality CAS14680-51-4.pdf  Good  quality CAS Good  quality CAS
14680-51-4.pdf Good quality CAS Good quality CAScathy664059
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationAnamaria Contreras
 
Effective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold JewelryEffective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold JewelryWhittensFineJewelry1
 
Driving Business Impact for PMs with Jon Harmer
Driving Business Impact for PMs with Jon HarmerDriving Business Impact for PMs with Jon Harmer
Driving Business Impact for PMs with Jon HarmerAggregage
 
Interoperability and ecosystems: Assembling the industrial metaverse
Interoperability and ecosystems:  Assembling the industrial metaverseInteroperability and ecosystems:  Assembling the industrial metaverse
Interoperability and ecosystems: Assembling the industrial metaverseSiemens
 
WSMM Technology February.March Newsletter_vF.pdf
WSMM Technology February.March Newsletter_vF.pdfWSMM Technology February.March Newsletter_vF.pdf
WSMM Technology February.March Newsletter_vF.pdfJamesConcepcion7
 
Strategic Project Finance Essentials: A Project Manager’s Guide to Financial ...
Strategic Project Finance Essentials: A Project Manager’s Guide to Financial ...Strategic Project Finance Essentials: A Project Manager’s Guide to Financial ...
Strategic Project Finance Essentials: A Project Manager’s Guide to Financial ...Aggregage
 
Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Americas Got Grants
 
Planetary and Vedic Yagyas Bring Positive Impacts in Life
Planetary and Vedic Yagyas Bring Positive Impacts in LifePlanetary and Vedic Yagyas Bring Positive Impacts in Life
Planetary and Vedic Yagyas Bring Positive Impacts in LifeBhavana Pujan Kendra
 
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptxThe-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptxmbikashkanyari
 
20200128 Ethical by Design - Whitepaper.pdf
20200128 Ethical by Design - Whitepaper.pdf20200128 Ethical by Design - Whitepaper.pdf
20200128 Ethical by Design - Whitepaper.pdfChris Skinner
 
TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024Adnet Communications
 
Guide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFGuide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFChandresh Chudasama
 
Cyber Security Training in Office Environment
Cyber Security Training in Office EnvironmentCyber Security Training in Office Environment
Cyber Security Training in Office Environmentelijahj01012
 
Welding Electrode Making Machine By Deccan Dynamics
Welding Electrode Making Machine By Deccan DynamicsWelding Electrode Making Machine By Deccan Dynamics
Welding Electrode Making Machine By Deccan DynamicsIndiaMART InterMESH Limited
 
Technical Leaders - Working with the Management Team
Technical Leaders - Working with the Management TeamTechnical Leaders - Working with the Management Team
Technical Leaders - Working with the Management TeamArik Fletcher
 
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdfGUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdfDanny Diep To
 
20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf
20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf
20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdfChris Skinner
 
Types of Cyberattacks - ASG I.T. Consulting.pdf
Types of Cyberattacks - ASG I.T. Consulting.pdfTypes of Cyberattacks - ASG I.T. Consulting.pdf
Types of Cyberattacks - ASG I.T. Consulting.pdfASGITConsulting
 

Dernier (20)

14680-51-4.pdf Good quality CAS Good quality CAS
14680-51-4.pdf  Good  quality CAS Good  quality CAS14680-51-4.pdf  Good  quality CAS Good  quality CAS
14680-51-4.pdf Good quality CAS Good quality CAS
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement Presentation
 
Effective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold JewelryEffective Strategies for Maximizing Your Profit When Selling Gold Jewelry
Effective Strategies for Maximizing Your Profit When Selling Gold Jewelry
 
Driving Business Impact for PMs with Jon Harmer
Driving Business Impact for PMs with Jon HarmerDriving Business Impact for PMs with Jon Harmer
Driving Business Impact for PMs with Jon Harmer
 
Interoperability and ecosystems: Assembling the industrial metaverse
Interoperability and ecosystems:  Assembling the industrial metaverseInteroperability and ecosystems:  Assembling the industrial metaverse
Interoperability and ecosystems: Assembling the industrial metaverse
 
WSMM Technology February.March Newsletter_vF.pdf
WSMM Technology February.March Newsletter_vF.pdfWSMM Technology February.March Newsletter_vF.pdf
WSMM Technology February.March Newsletter_vF.pdf
 
Strategic Project Finance Essentials: A Project Manager’s Guide to Financial ...
Strategic Project Finance Essentials: A Project Manager’s Guide to Financial ...Strategic Project Finance Essentials: A Project Manager’s Guide to Financial ...
Strategic Project Finance Essentials: A Project Manager’s Guide to Financial ...
 
Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...
 
Planetary and Vedic Yagyas Bring Positive Impacts in Life
Planetary and Vedic Yagyas Bring Positive Impacts in LifePlanetary and Vedic Yagyas Bring Positive Impacts in Life
Planetary and Vedic Yagyas Bring Positive Impacts in Life
 
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptxThe-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
 
20200128 Ethical by Design - Whitepaper.pdf
20200128 Ethical by Design - Whitepaper.pdf20200128 Ethical by Design - Whitepaper.pdf
20200128 Ethical by Design - Whitepaper.pdf
 
TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024TriStar Gold Corporate Presentation - April 2024
TriStar Gold Corporate Presentation - April 2024
 
Guide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFGuide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDF
 
Cyber Security Training in Office Environment
Cyber Security Training in Office EnvironmentCyber Security Training in Office Environment
Cyber Security Training in Office Environment
 
Welding Electrode Making Machine By Deccan Dynamics
Welding Electrode Making Machine By Deccan DynamicsWelding Electrode Making Machine By Deccan Dynamics
Welding Electrode Making Machine By Deccan Dynamics
 
WAM Corporate Presentation April 12 2024.pdf
WAM Corporate Presentation April 12 2024.pdfWAM Corporate Presentation April 12 2024.pdf
WAM Corporate Presentation April 12 2024.pdf
 
Technical Leaders - Working with the Management Team
Technical Leaders - Working with the Management TeamTechnical Leaders - Working with the Management Team
Technical Leaders - Working with the Management Team
 
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdfGUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
 
20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf
20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf
20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf
 
Types of Cyberattacks - ASG I.T. Consulting.pdf
Types of Cyberattacks - ASG I.T. Consulting.pdfTypes of Cyberattacks - ASG I.T. Consulting.pdf
Types of Cyberattacks - ASG I.T. Consulting.pdf
 

Beyond the Business Plan - Managing unexpected risks in biotechnology business development